Faruqi & Faruqi Reminds Pomdoctor Investors of Securities Class Action Deadline

Deadline for lead plaintiff role in Pomdoctor class action lawsuit is April 13, 2026.

Published on Feb. 14, 2026

Got story updates? Submit your updates here. ›

Faruqi & Faruqi, LLP, a national securities law firm, is investigating potential claims against Pomdoctor Limited (NASDAQ:POM) and is reminding investors of the April 13, 2026 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against the company. The lawsuit alleges that Pomdoctor and its executives violated federal securities laws through false and misleading statements and failure to disclose information about a fraudulent stock promotion scheme involving the company.

Why it matters

The lawsuit against Pomdoctor highlights growing concerns about stock manipulation and fraudulent promotion schemes targeting public companies. As an investor, understanding these types of legal actions and deadlines is crucial to protecting your financial interests.

The details

The complaint alleges that Pomdoctor was the subject of a fraudulent stock promotion scheme involving social media-based misinformation and impersonated financial professionals. It also claims that insiders and/or affiliates used offshore or nominee accounts to facilitate the coordinated dumping of shares during a price inflation campaign, and that Pomdoctor's public statements and risk disclosures omitted any mention of the false rumors and artificial trading activity driving the stock price. As a result, the company's positive statements about its business, operations, and prospects were allegedly materially misleading and/or lacked a reasonable basis.

  • Pomdoctor's stock experienced a significant decline between December 10 and December 11, 2025, falling from approximately $0.50 per share to about $0.38 per share, a drop of roughly 24% in a single trading session.
  • The deadline for investors to seek the role of lead plaintiff in the federal securities class action lawsuit against Pomdoctor is April 13, 2026.

The players

Pomdoctor Limited

A publicly traded company (NASDAQ:POM) that is the subject of a federal securities class action lawsuit alleging the company and its executives violated federal securities laws through false and misleading statements and failure to disclose information about a fraudulent stock promotion scheme.

Faruqi & Faruqi, LLP

A leading national securities law firm that is investigating potential claims against Pomdoctor and reminding investors of the deadline to seek the role of lead plaintiff in the class action lawsuit.

James (Josh) Wilson

A securities litigation partner at Faruqi & Faruqi, LLP who is encouraging investors who suffered losses in Pomdoctor to contact him directly to discuss their options.

Got photos? Submit your photos here. ›

What they’re saying

“If you purchased or acquired securities in Pomdoctor between October 9, 2025 and December 11, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).”

— James (Josh) Wilson, Securities Litigation Partner, Faruqi & Faruqi, LLP

What’s next

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member.

The takeaway

This case highlights the growing problem of stock manipulation and fraudulent promotion schemes targeting public companies, and the importance for investors to be vigilant and seek legal recourse when their financial interests are jeopardized by such activities.